In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies

OBJECTIVE(S): Lung cancer is the main leading cause of cancer death worldwide. Angiogenesis is the main step in proliferation and spreading of tumor cells. Targeting vascular endothelial growth factor (VEGF) is an effective approach for inhibition of cancer angiogenesis. Nanobodies (NBs) are a novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazemi-Lomedasht, Fatemeh, Pooshang-Bagheri, Kamran, Habibi-Anbouhi, Mahdi, Hajizadeh-Safar, Ensiyeh, Shahbazzadeh, Delavar, Mirzahosseini, Hasan, Behdani, Mahdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478776/
https://www.ncbi.nlm.nih.gov/pubmed/28656083
http://dx.doi.org/10.22038/IJBMS.2017.8672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478776/
https://www.ncbi.nlm.nih.gov/pubmed/28656083
http://dx.doi.org/10.22038/IJBMS.2017.8672

Ejemplares similares